Rationally designed base editors for precise editing of the sickle cell disease mutation

…, D Lam, Y Yu, J Marshall, LI Cheng, D Lam… - The CRISPR …, 2021 - liebertpub.com
Base editors are fusions of a deaminase and CRISPR-Cas ribonucleoprotein that allow
programmable installment of transition mutations without double-strand DNA break intermediates…

High-content synaptic phenotyping in human cellular models reveals a role for BET proteins in synapse assembly

…, JA Klein, D Trendafilova, SG Susco, D Lam… - Elife, 2023 - elifesciences.org
Resolving fundamental molecular and functional processes underlying human synaptic
development is crucial for understanding normal brain function as well as dysfunction in disease…

[HTML][HTML] Abiraterone acetate in metastatic castration-resistant prostate cancer–the unanticipated real-world clinical experience

…, K Chan, SH Lee, TW Chan, H Sze, EKC Lee, D Lam… - BMC urology, 2016 - Springer
Background There is much interest in confirming whether the efficacy of abiraterone acetate
(AA) demonstrated within the trial setting is reproducible in routine clinical practice. We …

[HTML][HTML] A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells

…, G Angelini, P Mazzucato, A Messana, D Lam… - Scientific reports, 2020 - nature.com
CRISPR-Cas9-mediated gene interference (CRISPRi) and activation (CRISPRa) approaches
hold promise for functional gene studies and genome-wide screens in human pluripotent …

[HTML][HTML] A randomized study of olanzapine-containing versus standard antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting in …

…, A Wong, WMT Soo, VTY Yeung, T Tse, DCM Lam… - The Breast, 2020 - Elsevier
Objectives Chemotherapy-induced nausea and vomiting (CINV) are distressing symptoms.
This randomized study evaluated the antiemetic efficacies of standard antiemetic regimen …

Dynamic changes of post-radiotherapy plasma Epstein–Barr virus DNA in a randomized trial of adjuvant chemotherapy versus observation in nasopharyngeal cancer

EP Hui, BBY Ma, WKJ Lam, KCA Chan, F Mo… - Clinical Cancer …, 2021 - AACR
… WKJ Lam reports other from Grail, Inc. outside the submitted work; in addition, WKJ Lam has
multiple patent applications on molecular diagnostics using cell-free nucleic acids pending. …

[HTML][HTML] Nerve fiber layer thinning lags retinal ganglion cell density following crush axonopathy

…, S Galeb, Y Liu, DC Landy, D Lam… - … & visual science, 2014 - jov.arvojournals.org
Purpose.: We investigated the progressive nature of neurodegenerative structural changes
following injury to retinal ganglion cell (RGC) axons using quantifiable and noninvasive in …

[PDF][PDF] Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models

…, A Beccard, V Barrera, MH Berryer, A Messana, D Lam… - Cell reports, 2022 - cell.com
Down syndrome (DS), driven by an extra copy of chromosome 21 (HSA21), and fragile X
syndrome (FXS), driven by loss of the RNA-binding protein FMRP, are two common genetic …

[HTML][HTML] Ethnic pharmacogenomic differences in the management of Asian patients with metastatic prostate cancer

…, K Chan, T Chan, FY Cheung, D Lam, M Lam… - Cancers, 2022 - mdpi.com
Simple Summary With the recognition that ethnicity may influence prognosis and outcomes,
there are ongoing controversies over how best to treat patients with prostate cancer. This …

[PDF][PDF] A scaled framework for CRISPR editing of human pluripotent stem cells to study psychiatric disease

…, N Dabkowski, A Messana, P Mazzucato, D Lam… - Stem cell reports, 2017 - cell.com
Scaling of CRISPR-Cas9 technology in human pluripotent stem cells (hPSCs) represents an
important step for modeling complex disease and developing drug screens in human cells. …